|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
24
|
|
pubmed:dateCreated |
1993-1-19
|
|
pubmed:abstractText |
Human adenovirus (Ad) can cause persistent infections in humans. Early region 3 (E3) of the virus appears to be implicated in this phenomenon. This transcription unit encodes proteins that interfere in various ways with host cell functions, including (i) cell-surface expression of histocompatibility class I antigens (HLA), (ii) cell-surface expression of the epidermal growth factor receptor (EGF-R), and (iii) the biological activity of tumor necrosis factor alpha (TNF-alpha). We transfected the human cell line 293 with the entire E3 region of Ad2 and investigated the influence of the cytokines TNF-alpha and interferon gamma (IFN-gamma) on cell-surface expression of HLA class I and the EGF-R. Whereas IFN-gamma treatment induced expression of HLA to some extent but not that of the EGF-R, TNF-alpha treatment augmented the reduction of these cell-surface molecules. Subsequent studies on the mechanism of this effect showed a TNF-alpha-dependent upregulation of E3 protein (E3/19K) and mRNA. The significance of this phenomenon was confirmed in infection experiments. A dramatic increase in the amount of E3/19K, even after short induction with low doses of TNF-alpha could be demonstrated. The study provides evidence for an interaction between the immune system and Ad in which the virus takes advantage of an immune mediator to escape immunosurveillance of the host.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-1386516,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-1831308,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-1836014,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-1848005,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-1851870,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-192073,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-2137259,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-2148290,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-2156934,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-2430188,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-2440339,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-2521704,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-2531778,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-2540776,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-2665943,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-2726753,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-2762307,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-2780296,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-2789254,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-2934137,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-2950523,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-2958275,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-2968712,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-3022155,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-3035018,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-3455781,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-3467330,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-3924414,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-423779,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-6088078,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-6190661,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-6286831,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-6336330,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-6355856,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-667938,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-6710160,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-6765173,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-886304,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334549-91522
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0027-8424
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
89
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
11857-61
|
|
pubmed:dateRevised |
2010-9-7
|
|
pubmed:meshHeading |
pubmed-meshheading:1334549-Adenoviridae Infections,
pubmed-meshheading:1334549-Adenovirus E3 Proteins,
pubmed-meshheading:1334549-Adenoviruses, Human,
pubmed-meshheading:1334549-Base Sequence,
pubmed-meshheading:1334549-Cell Membrane,
pubmed-meshheading:1334549-Gene Expression Regulation, Viral,
pubmed-meshheading:1334549-HLA Antigens,
pubmed-meshheading:1334549-HeLa Cells,
pubmed-meshheading:1334549-Humans,
pubmed-meshheading:1334549-Interferon-gamma,
pubmed-meshheading:1334549-Molecular Sequence Data,
pubmed-meshheading:1334549-Oligodeoxyribonucleotides,
pubmed-meshheading:1334549-RNA, Viral,
pubmed-meshheading:1334549-Receptor, Epidermal Growth Factor,
pubmed-meshheading:1334549-Transfection,
pubmed-meshheading:1334549-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
Tumor necrosis factor alpha stimulates expression of adenovirus early region 3 proteins: implications for viral persistence.
|
|
pubmed:affiliation |
Max-Planck-Institut für Immunobiologie, Spemann Laboratories, Freiburg, Germany.
|
|
pubmed:publicationType |
Journal Article,
In Vitro
|
